Company intelligence / Profile preview

Michigan Capital Network

Grand Rapids, Michigan, United States

Ownership: Private
Development stage: Other

Overview

MCN manages over $150M across multiple funds, with a portfolio exceeding 100 companies focused on healthcare/life science, advanced manufacturing, and software/technology. Its portfolio includes pre-clinical to commercial-stage companies but MCN itself is not developing specific therapeutics[1][5][7].

Industry: Investors

Partnerships

National Advanced Mobility Consortium (NAMC)Various university tech transfer offices and regional angel/VC groups

Beyond the preview

Go deeper on Michigan Capital Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Michigan Capital Network.

Explore the full profile